Palmitoylation-related gene signature as a prognostic biomarker and predictor of immunotherapy response in gastric cancer (KINGCA Week 2026) - Oct 11, 2026 - Abstract #PP-095; Pres time: Sep 18, 2026; 04:20 PM - 05:40 PM; Location: Sapphire 3+4; "Our results suggest that the PRGS may serve as a reliable prognostic biomarker for personalized therapy in GC patients."
Biomarker • Gene Signature • IO biomarker • Gastric Cancer • Oncology • Solid Tumor • OSBPL1A
|